The National Institute of Standards and Technology’s Artificial Intelligence Safety Institute is seeking information on the development of chemical and biology-focused artificial intelligence models.

The microbiome, the vast, tangled ecosystem of bacteria, fungi and other microbes that live in and on us, is increasingly recognised as a major factor in health, nutrition and drug response. A new ...

The MarketWatch News Department was not involved in the creation of this content. MIAMI, March 11, 2026 /PRNewswire/ -- Immorta Bio Inc., a scientific longevity biotechnology company dedicated to ...

Scientific Longevity Company to Present New Breakthrough Data at J.P. Morgan–Affiliated Biotech Showcase 2026 MIAMI and SAN DIEGO, Jan. 8, 2026 /PRNewswire/ -- Immorta Bio Inc., a scientific longevity ...

CAMBRIDGE, England--(BUSINESS WIRE)--bit.bio, the company coding human cells for novel cures, and the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London today announce ...

Tuesday, French drugmaker Sanofi SA (NASDAQ:SNY) announced its collaboration with OpenAI and Formation Bio to accelerate drug development projects. Also Read: Drugmaker Sanofi’s Strong Dupixent And ...

March 10, 2026) - R3 Bio announced the release of its 2026 research report outlining early-stage progress in developing integrated, stem cell-derived biological platforms designed to reduce reliance ...

Immorta Bio Inc. has reported new data demonstrating that its combination therapy of Senovax, a first-in-class senolytic immunotherapy, and personalized mesenchymal stem cells (pMSCs) from its ...

This review explores the intersection between large language models (LLMs) and cognitive science by examining similarities and differences between LLMs and human cognitive processes. It evaluates ...

MIAMI, March 11, 2026 /PRNewswire/ -- Immorta Bio Inc., a scientific longevity biotechnology company dedicated to Treating Diseases of Aging and Treating Aging as Disease™, today announced ...